These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents. Savateev K, Fedotov V, Butorin I, Eltsov O, Slepukhin P, Ulomsky E, Rusinov V, Litvinov R, Babkov D, Khokhlacheva E, Radaev P, Vassiliev P, Spasov A. Eur J Med Chem; 2020 Jan 01; 185():111808. PubMed ID: 31683103 [Abstract] [Full Text] [Related]
3. Synthesis and Evaluation of Novel [1,2,4]Triazolo[5,1-c][1,2,4]-triazines and Pyrazolo[5,1-c][1,2,4]triazines as Potential Antidiabetic Agents. Rusinov VL, Sapozhnikova IM, Bliznik AM, Chupakhin ON, Charushin VN, Spasov AA, Vassiliev PM, Kuznetsova VA, Rashchenko AI, Babkov DA. Arch Pharm (Weinheim); 2017 May 01; 350(5):. PubMed ID: 28393419 [Abstract] [Full Text] [Related]
4. Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetes. Brigance RP, Meng W, Fura A, Harrity T, Wang A, Zahler R, Kirby MS, Hamann LG. Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4395-8. PubMed ID: 20598534 [Abstract] [Full Text] [Related]
5. Synthesis, molecular modeling and bio-evaluation of cycloalkyl fused 2-aminopyrimidines as antitubercular and antidiabetic agents. Singh N, Pandey SK, Anand N, Dwivedi R, Singh S, Sinha SK, Chaturvedi V, Jaiswal N, Srivastava AK, Shah P, Siddiqui MI, Tripathi RP. Bioorg Med Chem Lett; 2011 Aug 01; 21(15):4404-8. PubMed ID: 21737274 [Abstract] [Full Text] [Related]
6. Synthesis of β-Ketoamide Curcumin Analogs for Anti-Diabetic and AGEs Inhibitory Activities. Banuppriya G, Sribalan R, Fathima SAR, Padmini V. Chem Biodivers; 2018 Aug 01; 15(8):e1800105. PubMed ID: 29752771 [Abstract] [Full Text] [Related]
7. Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic α-glucosidase inhibitors. Panahi F, Yousefi R, Mehraban MH, Khalafi-Nezhad A. Carbohydr Res; 2013 Oct 18; 380():81-91. PubMed ID: 23978663 [Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of stilbene derivatives coupled to NO donors as potential antidiabetic agents. Wang B, Liu T, Wu Z, Zhang L, Sun J, Wang X. J Enzyme Inhib Med Chem; 2018 Dec 18; 33(1):416-423. PubMed ID: 29374975 [Abstract] [Full Text] [Related]
9. Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo. Jung E, Kim J, Kim SH, Kim S, Cho MH. Eur J Pharmacol; 2014 Dec 05; 744():98-102. PubMed ID: 25448307 [Abstract] [Full Text] [Related]
10. Effects of polysaccharides from Inonotus obliquus and its chromium (III) complex on advanced glycation end-products formation, α-amylase, α-glucosidase activity and H2O2-induced oxidative damage in hepatic L02 cells. Wang C, Gao X, Santhanam RK, Chen Z, Chen Y, Xu L, Wang C, Ferri N, Chen H. Food Chem Toxicol; 2018 Jun 05; 116(Pt B):335-345. PubMed ID: 29689356 [Abstract] [Full Text] [Related]
11. Antiglycation therapy: Discovery of promising antiglycation agents for the management of diabetic complications. Abbas G, Al-Harrasi AS, Hussain H, Hussain J, Rashid R, Choudhary MI. Pharm Biol; 2016 Jun 05; 54(2):198-206. PubMed ID: 25853955 [Abstract] [Full Text] [Related]
12. Bis-coumarins; non-cytotoxic selective urease inhibitors and antiglycation agents. Salar U, Nizamani A, Arshad F, Khan KM, Fakhri MI, Perveen S, Ahmed N, Choudhary MI. Bioorg Chem; 2019 Oct 05; 91():103170. PubMed ID: 31408830 [Abstract] [Full Text] [Related]
13. Graphite catalyzed solvent free synthesis of dihydropyrimidin-2(1H)-ones/thiones and their antidiabetic activity. Dhumaskar KL, Meena SN, Ghadi SC, Tilve SG. Bioorg Med Chem Lett; 2014 Jul 01; 24(13):2897-9. PubMed ID: 24835627 [Abstract] [Full Text] [Related]
14. Antiglycation properties of aged garlic extract: possible role in prevention of diabetic complications. Ahmad MS, Ahmed N. J Nutr; 2006 Mar 01; 136(3 Suppl):796S-799S. PubMed ID: 16484566 [Abstract] [Full Text] [Related]
15. Novel class of hybrid natural products as antidiabetic agents. Raj K, Misra N, Pachauri G, Sharma M, Tamrakar AK, Singh AB, Srivastava AK, Phani Kiran K, Narasimha Rao CV, Prubhu SR. Nat Prod Res; 2009 Mar 01; 23(1):60-9. PubMed ID: 19140071 [Abstract] [Full Text] [Related]
16. Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitors. Meng W, Brigance RP, Chao HJ, Fura A, Harrity T, Marcinkeviciene J, O'Connor SP, Tamura JK, Xie D, Zhang Y, Klei HE, Kish K, Weigelt CA, Turdi H, Wang A, Zahler R, Kirby MS, Hamann LG. J Med Chem; 2010 Aug 12; 53(15):5620-8. PubMed ID: 20684603 [Abstract] [Full Text] [Related]
17. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors. Patel BD, Bhadada SV, Ghate MD. Bioorg Chem; 2017 Jun 12; 72():345-358. PubMed ID: 28302310 [Abstract] [Full Text] [Related]
18. Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases. Zhang L, Chen J, Gong Y, Liu J, Zhang L, Hua W, Sun H. Chem Biodivers; 2009 Jun 12; 6(6):864-74. PubMed ID: 19551727 [Abstract] [Full Text] [Related]
19. Synthesis of New Series of 2-C-(β-D-glucopyranosyl)-Pyrimidines and Their Evaluation as Inhibitors of Some Glycoenzymes. Szennyes E, Gyémánt G, Somsák L, Bokor É. Molecules; 2020 Feb 06; 25(3):. PubMed ID: 32041285 [Abstract] [Full Text] [Related]
20. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione. Lee HW, Kim BY, Ahn JB, Kang SK, Lee JH, Shin JS, Ahn SK, Lee SJ, Yoon SS. Eur J Med Chem; 2005 Sep 06; 40(9):862-74. PubMed ID: 15908051 [Abstract] [Full Text] [Related] Page: [Next] [New Search]